Refreshing results…
Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetes
Download from doi.orgHigh Prevalence of Intraductal Papillary Mucinous Neoplasms in Type 2 Diabetes Mellitus Patients
UploadGLP-1 receptor agonists, CKD, and eGFR trajectory
UploadRenal outcomes in CVOTs: keep calm and carry on
UploadMissing publications? Search for publications with a matching author name.